Significant results in the commercialization of scientific developments and industry collaboration have been achieved during the first operational phase of the Biomedical and Photonics Innovation Platform BioPhoT.

Among the 66 innovation projects implemented across Latvia, the Institute of Solid State Physics, University of Latvia (ISSP UL) made a substantial contribution – our researchers developed 15 standalone projects while also making key contributions to initiatives led by partner institutions.

The participation of ISSP UL scientists in the platform demonstrates high interdisciplinary potential in areas such as photonics, optical sensing, biomaterials, and advanced functional materials.

The main performance metrics of the platform's first phase are available on the BioPhoT website.

Through commercialization coaching, international investor outreach (including participation in the Hello Tomorrow Global Summit 2026), and collaboration with industrial clusters, our research teams have gained real momentum in turning their technologies and methods into licensed products or successful commercial ventures. In this regard, the BioPhoT platform has proven to be a truly essential instrument for the development of deep tech in Latvia.

Share